I

Immunovant
D

IMVT

25.800
USD
-0.10
(-0.39%)
Market Closed
Volume
18,550
EPS
-2
Div Yield
-
P/E
-12
Market Cap
3,787,043,686
OverviewSignalsIdeasNews
Related Instruments
    AAPL
    AAPL
    0.79
    (0.31%)
    255.36 USD
    A
    AFRM
    -0.690
    (-1.05%)
    64.940 USD
    AMZN
    AMZN
    -0.010
    (-0.00%)
    225.080 USD
    AXP
    AXP
    0.13
    (0.04%)
    298.87 USD
    MA
    MA
    0.38
    (0.07%)
    528.77 USD
    PYPL
    PYPL
    -0.240
    (-0.28%)
    86.880 USD
    SQ
    SQ
    -0.330
    (-0.37%)
    89.290 USD
    V
    V
    -0.65
    (-0.20%)
    317.09 USD
    More
News

Title: Immunovant

Sector: Healthcare
Industry: Biotechnology
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).